David Sacks, Anthropic, & the White House, Regeneron’s Deafness Cure 4/24/26
Regeneron's gene therapy for inherited deafness is now FDA-approved and free for Americans. CEO Leonard Schleifer discusses this breakthrough, AI's role in medical innovation, and future advancements. David Sacks, advisor to President Trump on AI and crypto, shares insights on…